Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $38,524 | 19 | 90.8% |
| Food and Beverage | $1,626 | 53 | 3.8% |
| Travel and Lodging | $1,175 | 4 | 2.8% |
| Honoraria | $1,080 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $20,464 | 21 | $0 (2024) |
| Genentech, Inc. | $12,734 | 9 | $0 (2024) |
| Genentech USA, Inc. | $2,881 | 2 | $0 (2023) |
| F. Hoffmann-La Roche AG | $2,760 | 2 | $0 (2022) |
| Corium, LLC | $1,550 | 1 | $0 (2023) |
| Lundbeck LLC | $1,202 | 8 | $0 (2024) |
| Kyowa Kirin, Inc. | $202.22 | 8 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $166.04 | 9 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $165.64 | 4 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $69.37 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,428 | 14 | Eisai Inc. ($3,844) |
| 2023 | $27,222 | 28 | Eisai Inc. ($16,620) |
| 2022 | $8,182 | 9 | F. Hoffmann-La Roche AG ($2,760) |
| 2021 | $60.73 | 3 | Adamas Pharmaceuticals, Inc. ($40.28) |
| 2020 | $49.28 | 2 | Allergan, Inc. ($26.97) |
| 2019 | $112.29 | 6 | Adamas Pharmaceuticals, Inc. ($39.27) |
| 2018 | $245.16 | 9 | Sunovion Pharmaceuticals Inc. ($121.44) |
| 2017 | $105.55 | 6 | Impax Laboratories, Inc. ($37.84) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Honoraria | Cash or cash equivalent | $1,080.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/25/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $3,510.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $98.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $55.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $42.00 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $19.00 | General |
| Category: Neurology | ||||||
| 05/01/2024 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 04/16/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Adenosine A2A Receptors | ||||||
| 04/08/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $23.77 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Adenosine A2A Receptors | ||||||
| 02/28/2024 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $690.00 | General |
| 01/11/2024 | Eisai Inc. | — | Food and Beverage | In-kind items and services | $119.90 | General |
| 01/09/2024 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: Parkinson's Disease | ||||||
| 12/26/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,380.00 | General |
| 12/06/2023 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $1,755.00 | General |
| 11/28/2023 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| 11/28/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,207.00 | General |
| 11/21/2023 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $3,510.00 | General |
| Category: Neurology | ||||||
| 11/21/2023 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $387.66 | General |
| Category: Neurology | ||||||
| 11/21/2023 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $322.15 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,207.50 | General |
| 10/28/2023 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $215.00 | General |
| Category: Neurology | ||||||
| 10/28/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $54.40 | General |
| Category: Neurology | ||||||
| 10/28/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $54.31 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 24 | 25 | $27,375 | $3,542 |
| 2021 | 1 | 16 | 16 | $17,520 | $3,015 |
| 2020 | 3 | 48 | 49 | $26,105 | $6,326 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 25 | $27,375 | $3,542 | 12.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $17,520 | $3,015 | 17.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 25 | $6,250 | $2,523 | 40.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 12 | $11,280 | $2,292 | 20.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 12 | $8,575 | $1,512 | 17.6% |
About Jessica Zwerling, MD, MS
Jessica Zwerling, MD, MS is a Neurology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053496364.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Zwerling, MD, MS has received a total of $42,405 in payments from pharmaceutical and medical device companies, with $6,428 received in 2024. These payments were reported across 77 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($38,524).
As a Medicare-enrolled provider, Zwerling has provided services to 88 Medicare beneficiaries, totaling 90 services with total Medicare billing of $12,884. Data is available for 3 years (2020–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Bronx, NY
- Active Since 10/26/2006
- Last Updated 04/11/2012
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1053496364
Products in Payments
- Leqembi (Drug) $12,739
- Adlarity (Drug) $1,550
- REXULTI (Drug) $1,080
- Nourianz (Drug) $179.49
- GOCOVRI (Drug) $166.04
- APTIOM (Drug) $165.64
- Ocrevus (Biological) $121.24
- NORTHERA (Drug) $107.17
- INBRIJA (Drug) $65.00
- Ongentys (Drug) $43.10
- RYTARY (Drug) $37.84
- BOTOX (Biological) $26.97
- INGREZZA (Drug) $26.27
- FIRDAPSE (Drug) $23.77
- ULTOMIRIS (Biological) $22.91
- NOURIANZ (Drug) $22.73
- OSMOLEX ER (Drug) $18.38
- ACTIVA (Device) $15.32
- ONFI (Drug) $15.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bronx
Richard Lipton, Md, MD
Neurology — Payments: $982,914
Michael Thorpy, Md, MD
Neurology — Payments: $451,587
Rene Elkin, Md, MD
Neurology — Payments: $343,327
Jelena Pavlovic, M.d, M.D
Neurology — Payments: $130,235
Dr. Sandeep Gulati, D.o, D.O
Neurology — Payments: $124,853
Dr. Lauren Gluck, Md, MD
Neurology — Payments: $53,848